ProCE Banner Activity

Generalized Pustular Psoriasis: Diagnosis and Treatment Options

Clinical Thought

A diagnosis of life-threatening generalized pustular psoriasis (GPP) requires the exclusion of several other diagnoses presenting with pustules. In this commentary Alice Gottlieb, MD, PhD discusses the importance of an early and accurate diagnosis, which laboratory tests are helpful, and the newest, targeted treatment option available.

Released: September 17, 2022

Expiration: September 16, 2023

No longer available for credit.

Share

Faculty

Alice Gottlieb

Alice Gottlieb, MD, PhD

Clinical Professor
Department of Dermatology
Icahn School of Medicine at Mount Sinai
Medical Director
Department of Dermatology
Mount Sinai-Union Square
New York, New York

Provided by

Provided by Partners for Advancing Clinical Education (PACE)

ProCE Banner
ProCE Banner

Supporters

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.

Faculty Disclosure

Primary Author

Alice Gottlieb, MD, PhD

Clinical Professor
Department of Dermatology
Icahn School of Medicine at Mount Sinai
Medical Director
Department of Dermatology
Mount Sinai-Union Square
New York, New York

Alice Gottlieb, MD, PhD: consultant/advisor: AnaptsysBio, Amgen, Avotres Therapeutics, Boehringer Ingelheim, Bristol-Myers Squibb Co, Dermavant, Eli Lilly, Janssen, Novartis, Pfizer, Sanofi, Sun Pharmaceutical Industries, UCB; stock options: Xbiotech (for a rheumatoid arthritis program); research (paid to institution): AnapytsysBio, Bristol-Myers Squibb, Janssen, Novartis, Ortho, Sun Pharmaceutical, UCB.